Evidence map›Paper›PMID 33100858›Full record

ArticleSaudi journal of biological sciences2020

Mysoon M Al-Ansari, P Dhasarathan, A J A Ranjitsingh, Latifah A Al-Humaid

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Chitosan and naringenin-coated silver nanoparticles as a nanoplatform against drug-resistant uropathogens.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  4. Article
  5. Unlocking the Potential ofPharmaceutics · 2025
    Review
  6. Review
  7. Exploring the health benefits ofFrontiers in cellular and infection microbiology · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Materials (Basel, Switzerland) · 2023
    Article
  12. Review
  13. Article
  14. Microbial silver resistance mechanisms: recent developments.World journal of microbiology & biotechnology · 2022
    Review
  15. Article
  16. Frontiers in pharmacology · 2022
    Review
  17. Green Metallic Nanoparticles: Biosynthesis to Applications.Frontiers in bioengineering and biotechnology · 2022
    Review
  18. Article
  19. Review
  20. Green Synthesis of Silver Nanoparticles Using the Flower Extract ofInternational journal of nanomedicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mysoon M Al-AnsariDepartment of Botany and Microbiology, Female Campus, College of Science, King Saud University, Riyadh, Saudi Arabia.
P DhasarathanDepartment of Biotechnology, Prathyusha Engineering College, Chennai 600056, India.
A J A RanjitsinghDepartment of Biotechnology, Prathyusha Engineering College, Chennai 600056, India.
Latifah A Al-HumaidDepartment of Botany and Microbiology, Female Campus, College of Science, King Saud University, Riyadh, Saudi Arabia.
King Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the search for alternative therapy for infections and other ailments, metallic nanoparticles, mainly silver nanoparticles (AgNPs) synthesized through bioengineered sources are extensively explored. Fungal bioactive compounds and their nanoparticles were reported with the potential biomedical application. A medicinal mushroom

Indexed as

Antibacterial activityAntioxidantBreast cancer cell lineGanoderma lucidumUrinary tract infection

Identifiers

PMID33100858
PMCPMC7569111
OpenAlexW3086122772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.